Читать книгу Assisted Reproduction Techniques - Группа авторов - Страница 89

1 1 Stephenson JL, Shipman AR. The Systemic Lupus International Collaborating Clinics criteria have replaced the American College of Rheumatology guidelines for the diagnosis of systemic lupus erythematosus. Clin Exp Dermatol. 2014; 39(3): 431–2.

2 2 Rúa‐Figueroa Fernández de Larrinoa I. What is new in systemic lupus erythematosus. Reumatol Clin. 2015; 11(1): 27–32.

3 3 Mackillop LH, Germain SJ, Nelson‐Piercy C. Systemic lupus erythematosus. BMJ. 2007; 335: 933–6.

4 4 Oktem O, Guzel Y, Aksoy S, Aydin E, Urman B. Ovarian function and reproductive outcomes of female patients with systemic lupus erythematosus and the strategies to preserve their fertility. Obstet. Gynecol. Surv. 2015; 70(3): 196–210.

5 5 Gasparin AA, Souza L, Siebert M, Xavier RM, Chakr RM, Palominos PE, et al. Assessment of anti‐Mullerian hormone levels in premenopausal patients with systemic lupus erythematosus. Lupus. 2016; 25: 227–232.

6 6 Harward LE, Mitchell K, Pieper C, Copland S, Criscione‐Schreiber LG, Clowse ME. The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease. Lupus. 2013; 22: 81–86.

7 7 Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, et al. Antiphospholipid syndrome: state of the art on clinical practice guidelines. Limper M. RMD Open. 2018; 4(Suppl 1): e000785.

8 8 Practice Committee of American Society for Reproductive Medicine. Anti‐phospholipid antibodies do not affect IVF success. Fertil. Steril. 2008; 90: S172–S173.

9 9 Andreoli L, Bertsias GK, Agmon‐Levin N, Brown S, Cervera R, Costedoat‐Chalumeau N. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann. Rheum. Dis. 2017; 76(3): 476–85.

10 10 Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum. 2000; 43(3): 550–6.

11 11 Bellver J, Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertil. Steril. 2009; 92: 1803–10.

12 12 Huong DLT, Wechsler B, Vauthier‐Brouzes D, Duhaut P, Costedoat N, Lefebvre G, et al. Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles. Semin. Arthritis Rheum. 2002; 32: 174–88.

13 13 Orquevaux P, Masseau A, Le Guern V, Gayet V, Vauthier D, Guettrot‐Imbert G, et al. in vitro Fertilization in 37 Women with Systemic Lupus Erythematosus or Antiphospholipid Syndrome: A Series of 97 Procedures. J. Rheumatol. 2017; 44(5): 613–8.

14 14 Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N. Engl. J. Med. 2005; 353: 2550e2558.

15 15 Brito‐Zerón P, Izmirly PM, Ramos‐Casals M, Buyon JP, Khamashta MA. The clinical spectrum of autoimmune congenital heart block. Nat. Rev. Rheumatol. 2015; 11: 301–12.

16 16 Bundhun PK, Soogund MZ, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta‐analysis of studies published between years 2001–2016. J. Autoimmun. 2017; 79: 17–27.